Kodiak Sciences Inc.

NASDAQ:KOD

Biotechnology

Healthcare
$97.81 -0.08%

-$0.03 today

Market cap
$6.40B
Beta
2.21
P/E (TTM)
-9.6
EPS (TTM)
-$3.73
52W Low $3.43High $47.84

Volume 0.74M

Average 1.10M

KOD Other Non-current Liabilities

Long-term obligations not reported separately, such as lease or pension liabilities.

Kodiak Sciences Inc.NASDAQ: KOD

Other Non-current Liabilities · Q3 FY2026 · quarter ended Sep 2026

Other non-current liabilities falls 99.2% from a year ago

Other non-current liabilities stood at $826K at the end of Q3 FY2026, down 99.2% from a year earlier and down 98.6% from the prior quarter. Over 3 fiscal years it compounded at +110.0% a year.

Context

  • Other non-current liabilities amounted to 0.4% of total assets at the end of Q3 FY2026, down 46.2 pp from a year earlier.
  • Other non-current liabilities increased in 1 of the last 3 fiscal years.

What to watch

Whether other non-current liabilities keeps falling in the next quarterly balance sheet after a -99.2% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterSep 2026
$826K-98.6% QoQ
Last fiscal yearDec 2025
$1.5M-98.5% YoY
Year agoSep 2025
$101.5M-99.2% since
Other Non-current Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-99.2%——
1 year-98.5%——
3-year CAGR+110.0%——
5-year CAGR——
10-year CAGR——

Other Non-current Liabilities history

USD · from the balance sheet

Latest · FY2025
1.5M USD
Year-over-year change
-98.5%
4-year CAGR
+63.3%

Other Non-current Liabilities vs competitors

How KOD compares with its peers on the latest reported figures

  • Peers report in different currencies, so other non-current liabilities is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -99.2% is the 9th highest of 10, against a peer median of -7.3%.
  • Other non-current liabilities amounts to 0.4% of total assets for KOD, versus a peer median of 1.8%.
KOD Competitors
Other Non-current Liabilities for KOD and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
REGNRegeneron Pharmaceuticals, Inc.Jun 2026$2.5B USD+47.0%+46.8%6.0%
BLCOBausch + Lomb CorporationJun 2026$435M USD-19.3%+4.6%3.1%
OCULOcular Therapeutix, Inc.Mar 2026$12.98M USD-7.3%+22.9%1.8%
OCGNOcugen, Inc.Mar 2026$2.95M USD+415.0%+87.3%5.2%
OCSOculis Holding AGMar 2026CHF 1.65M CHF+27.1%+144.9%0.7%
KODKodiak Sciences Inc.Sep 2026$826K USD-99.2%+110.0%0.4%
OTLKOutlook Therapeutics, Inc.Mar 2026$722.23K USD-86.8%+337.0%3.3%
FDMT4D Molecular Therapeutics, Inc.Mar 2026$491K USD-1.6%+28.6%0.1%
EYPTEyePoint Pharmaceuticals, Inc.Mar 2026$55K USD-68.9%-47.5%0.0%
BLTEBelite Bio, IncJun 2026$0 USD-100.0%—0.0%
Peer median (excluding KOD) —-7.3%+37.7%1.8%

Competitors are the stored peer set for KOD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents731.51M190.43M285.51M168.07M209.86M
Short-term Investments0288.5M000
Net Receivables00000
Inventory00000
Other Current Assets3.3M7.07M3.8M3.86M4.95M
Total Current Assets734.81M486.01M289.31M171.94M214.82M
Property, Plant & Equipment (Net)108.07M115.75M175.02M148.73M121.86M
Goodwill00000
Intangible Assets00000
Long-term Investments6.32M6.32M6.32M6.18M6.18M
Tax Assets00000
Other Non-current Assets55.01M58.55M8.72M8.73M8.67M
Total Non-current Assets169.41M180.62M190.06M163.64M136.72M
Total Assets904.22M666.63M479.37M335.58M351.53M
Account Payables12.43M9.13M13.61M3.92M12.86M
Short-term Debt3.93M9.93M9.77M012.06M
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities42.13M27.41M12.27M012.84M
Total Current Liabilities64.68M52.5M41.73M25.57M45.53M
Long-term Debt99.94M100M100M0100M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities211K162K0100M1.5M
Total Non-current Liabilities176.22M177.97M171.86M159.72M148.62M
Total Liabilities240.9M230.46M213.59M185.29M194.15M
Common Stock5K5K5K5K6K
Retained Earnings(558.22M)(892.04M)(1.15B)(1.33B)(1.56B)
Accumulated OCI0(1.31M)000
Other Stockholders Equity00000
Minority Interest00000
Total Equity663.32M436.17M265.78M150.29M157.38M
Total Debt179.94M187.73M181.63M70.35M159.18M
Net Debt(551.57M)(2.7M)(103.88M)(97.73M)(50.68M)

Kodiak Sciences Inc.

NASDAQ:KOD

Intrinsic Alpha fair value

Locked

Current Price

$97.81

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.